Open Label, Multi-center, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous CAR BCMA T Cells (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)
- Ganguly, Siddhartha (PI)
- Petkova, Jenny (Key Personnel)
- Pingali, S. Ravi (Key Personnel)
- Shah, Shilpan (Key Personnel)
Project: Clinical Trial